ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,127 | -54.8% | 21,905 | -40.1% | 0.00% | – |
| Q3 2022 | $18,000 | +50.0% | 36,591 | +82.6% | 0.00% | – |
| Q2 2022 | $12,000 | -98.3% | 20,035 | -96.3% | 0.00% | -100.0% |
| Q4 2021 | $716,000 | +400.7% | 542,212 | +2654.7% | 0.00% | – |
| Q1 2021 | $143,000 | -64.8% | 19,683 | -79.0% | 0.00% | -100.0% |
| Q4 2020 | $406,000 | -7.1% | 93,932 | +29.1% | 0.00% | -50.0% |
| Q2 2020 | $437,000 | +9.5% | 72,752 | +37.2% | 0.00% | -33.3% |
| Q1 2020 | $399,000 | +33.9% | 53,015 | +144.5% | 0.00% | +200.0% |
| Q4 2019 | $298,000 | – | 21,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |